Tech Company Financing Transactions
Harbour BioMed Funding Round
On 8/28/2018, Harbour BioMed received $85 million in Series B funding from GIC, Advantech and China Life Insurance.
Transaction Overview
Company Name
Announced On
8/28/2018
Transaction Type
Venture Equity
Amount
$85,000,000
Round
Series B
Investors
Proceeds Purpose
Series B round financing to accelerate the growth of its innovative therapeutic pipeline, including both clinical and discovery stage programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jingsong Wang
VP - Bus. Development
Xiaoxiang Chen
VP - Bus. Development
Atul Deshpande
VP - Bus. Development
Mai-Jing Liao
VP - Engineering
Louis Liu
Browse more venture capital transactions:
Prev: 8/27/2018: Neurelis venture capital transaction
Next: 8/28/2018: Goose venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs